Skip to main
  1. Stocks
  2. Thermo Fisher Scientific
  3. Forecast
TMO

TMO Stock Forecast & Price Target

TMO Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 33%
Buy 44%
Hold 22%
Sell 0%
Strong Sell 0%

Bulls say

Thermo Fisher Scientific is well positioned because its 3Q organic revenue growth of 6% exceeded expectations, driven by strong momentum in Lab Products and Biopharma Services, where Pharma Services grew in the mid-to-high teens, and by Analytical Instruments’ 6% organic growth. Management raised FY26 revenue guidance to $47.7–48.2B and EPS to $25.13–25.43 while keeping about 4% organic growth intact, suggesting confidence that demand is improving rather than merely benefiting from timing. The company also showed resilient end-market breadth, with pharma and biotech, industrial and applied, and China improving, while margin expansion to 24.5% underscores operating leverage and a high-quality earnings profile.

Bears say

Thermo Fisher Scientific is viewed negatively because end-market demand normalization in scientific lab supply has taken years to materialize and may continue to disappoint after many false starts. Its growth profile also looks challenged, with 2026 organic sales guidance of about 3%-4% well below the long-term 7% target, while a large M&A platform may no longer earn the same valuation premium as scarce targets and pharma services expansion replace earlier consolidation wins. AI adds another overhang, since clinical research is about 20% of sales and core scientific research supply about 40%, both exposed to automation and wet-lab substitution concerns that could pressure growth and multiple support.

TMO has been analyzed by 18 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 44% recommend Buy, 22% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Thermo Fisher Scientific and is not a guaranteed prediction by Public.com or investment advice.

TMO Analyst Forecast & Price Prediction

Get the latest TMO stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in TMO

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Thermo Fisher Scientific (TMO) Forecast

Analysts have given TMO a Buy based on their latest research and market trends.

According to 18 analysts, TMO has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $691.61, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $691.61, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Thermo Fisher Scientific (TMO)


TMO Analyst Forecast & Price Prediction

Get the latest TMO stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in TMO

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover TMO stock data and trends